ODC Oil-Dri Corp. Of America

Susan Kreh Announced as Chief Financial Officer

Susan Kreh Announced as Chief Financial Officer

CHICAGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Oil-Dri Corporation of America (NYSE: ODC) announced that effective today, Susan M. Kreh has been appointed Chief Financial Officer. In her role as CFO, Ms. Kreh will report directly to Daniel S. Jaffee, Oil-Dri’s President and Chief Executive Officer. She will oversee the finance, accounting, and information technology functions of the company and will engage with our business units to help them achieve their long-term growth goals.

“We are excited to welcome Susan to the Oil-Dri family and believe her professional experience, broad business acumen and international expertise will be a great asset to our business,” said Daniel S. Jaffee. “In her career, Susan has proven herself as a successful leader, and I am confident that her strategic direction will further elevate Oil-Dri.”

Ms. Kreh was previously with Johnson Controls International plc, where she served as Chief Financial Officer and VP, Information Technology, of the Power Solutions business, from 2010 to 2017 and Corporate Controller from 2007 to 2010. During her tenure she drove the transformation and performance of the business, resulting in significant revenue growth. Prior to Johnson Controls, Ms. Kreh served in finance and operational leadership roles at PPG Industries, Inc. from 1985 to 2007, including Treasurer, General Manager of the global optical materials business and Director, Financial Services and Support of the specialty chemicals business.

Ms. Kreh earned her Bachelor’s degree in Business Administration from the University of Wisconsin with majors in Accounting and Analysis & Design of Business Information Systems in 1985 and her MBA in Finance from Duquesne University in 1989.  Ms. Kreh serves on the Board of Directors of TAPCO, Inc. and on the Advisory Board of the University of Wisconsin Graduate School of Business’s Corporate Finance & Investment Banking Program.

While Oil-Dri’s founding product was granular clay floor absorbents, it has since greatly diversified its portfolio. The Company’s mission to “Create Value from Sorbent Minerals” is supported by its wide array of consumer and business to business product offerings. In 2016, Oil-Dri celebrated its seventy-fifth year of business and looks forward to the next milestone. To learn more about the Company, visit .

Reagan B. Culbertson

Investor Relations Manager



(312) 321-1515

EN
10/12/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Oil-Dri Corp. Of America

 PRESS RELEASE

Oil-Dri’s Board of Directors Declares Quarterly Dividends

Oil-Dri’s Board of Directors Declares Quarterly Dividends CHICAGO, March 12, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Oil-Dri Corporation of America (NYSE: ODC) yesterday declared quarterly cash dividends of $0.205 per share of the Company’s Common Stock and $0.153 per share of the Company’s Class B Stock. The cash dividends will be payable on May 22, 2026 to stockholders of record at the close of business on May 8, 2026. Oil-Dri has paid cash dividends continuously each year since 1974 and has increased dividends annually for twenty-two consecutive years. The Company’s press ...

 PRESS RELEASE

Oil-Dri Announces Highest Second Quarter Revenues on Record

Oil-Dri Announces Highest Second Quarter Revenues on Record CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its second quarter and first six- months of fiscal year 2026.  Second QuarterYear to Date(in thousands, except per share amounts)Ended January 31,Ended January 31, 20262025Change20262025ChangeConsolidated Results      Net Sales$117,737$116,9141 %$238,223$244,859(3)%Income from Operations *$15,693$17,482(10)%$32,647$38,672(16)%Net Income$12,569$12,921(3)%$28,025$29,2...

 PRESS RELEASE

Amlan International and Elanco Collaborate on Japanese Educational Sem...

Amlan International and Elanco Collaborate on Japanese Educational Seminars Focused on Calf Health CHICAGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Amlan® International, the animal health business of Oil-Dri® Corporation of America (NYSE: ODC), will collaborate with Elanco Animal Health on a three-day educational seminar in Japan from March 10–12 titled: “Creating the Future for Calves: Latest Clinical Approaches for Suckling Calves.” The program will bring together veterinarians, producers, and industry stakeholders to exchange practical knowledge and field-based experience related to the mana...

 PRESS RELEASE

Amlan International to Showcase Swine Gut Health Innovations at AMVECA...

Amlan International to Showcase Swine Gut Health Innovations at AMVECAJ 2026 in Partnership with KOFARM CHICAGO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Amlan® International, the animal health business of Oil-Dri® Corporation of America (NYSE: ODC), will exhibit at the XXXII AMVECAJ International Congress, taking place from February 4-6, 2026, in Tepatitlán de Morelos, Jalisco, Mexico. Amlan will be located at Booth 14, co-sponsoring the event alongside its valued distribution partner KOFARM, reinforcing a shared commitment to advancing swine gut health and production performance across Mexico....

 PRESS RELEASE

Amlan® International Announces Promotion of Dr. Robin Jarquin to Vice ...

Amlan® International Announces Promotion of Dr. Robin Jarquin to Vice President of Sales – Latin America CHICAGO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Amlan® International, the animal health business of Oil-Dri® Corporation of America (NYSE: ODC), is pleased to announce the promotion of Dr. Robin Jarquin to Vice President of Sales, Latin America. In this expanded leadership role, Dr. Jarquin will leverage his deep industry experience and strong regional expertise to drive sales growth and further expand Amlan’s presence across Latin American markets.Dr. Jarquin joined Amlan in 2023 as Direct...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch